Top Markets
Coin of the day
Hybio Pharmaceutical Co., Ltd. Hybio Pharmaceutical Co., Ltd.

Hybio Pharmaceutical Co., Ltd.

300199
Classifica tra le azioni #5173
Established in 1998 and headquartered in Shenzhen, China, Hybio Pharmaceutical... Established in 1998 and headquartered in Shenzhen, China, Hybio Pharmaceutical Co., Ltd. specializes in the global research, development, manufacturing, and commercialization of therapeutic peptide active pharmaceutical ingredients (APIs) and polypeptide medications. Its diverse product range addresses therapeutic needs such as diabetes (including liraglutide, semaglutide, and exenatide), gastrointestinal and metabolic disorders (with examples like terlipressin, desmopressin, and linaclotide), as well as applications in obstetrics and gynecology (featuring ganirelix, cetrorelix, and atosiban). Additionally, the company supplies custom peptides and provides essential working standards for peptide APIs and their impurities, offering comprehensive support for development initiatives. Beyond products, Hybio extends its expertise through Contract Research Organization (CRO) and an extensive Contract Development and Manufacturing Organization (CDMO) platform. This platform covers peptide API synthesis and purification process optimization, finished dosage form conceptualization, reference standard preparation and rigorous qualification, detailed impurity and product quality analysis, Good Manufacturing Practice (GMP) systems adhering to both EU and FDA benchmarks, and comprehensive regulatory and dossier support for both international and Chinese markets.
Prezzo delle azioni
$3.33
Capitalizzazione di mercato
$2.95B
Variazione (1 giorno)
1.50%
Variazione (1 anno)
-8.64%
Paese
CN
Scambia Hybio Pharmaceutical Co., Ltd. (300199)

Categoria

Storico del prezzo dell'azione per Hybio Pharmaceutical Co., Ltd. (300199)
Prezzo di chiusura più alto: $3.56 il 2026-08-01

Prezzo di chiusura più basso: $0.58 il 2011-04-01
Storico del prezzo dell'azione di Hybio Pharmaceutical Co., Ltd. dal 2011 al 2026
Andamento annuale del prezzo dell'azione
Anno Performance
2026 (TTM) 15.17%
2025 42.29%
2024 -6.38%
2023 -30.94%
2022 109.62%
2021 23.92%
2020 37.43%
2019 -46.61%
2018 -38.55%
2017 -7.67%
2016 -34.21%
2015 61.85%
2014 66.85%
2013 185.59%
2012 -33.66%
2011 0.00%
Prezzo dell'azione per aziende simili o concorrenti
Azienda Prezzo dell'azione Variazione 1a% Il paese
$171.67 -
DE
$164.46 30.68%
DE
$37.90 27.13%
JP
$222.40 27.19%
CH
$21.11 15.61%
IN